Use of Lesion Response Rate in Actinic Keratosis Trials
Complete patient clearance is often required by regulatory agencies for the approval of treatments for actinic keratosis (AK). However, an increasing number of clinicians have challenged the use of this measure in clinical practice and its interpretation. It has been argued that complete patient cle...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Healthcare
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120634/ |